Search

FDA Reports of Secondary Malignancies Following Chimeric Antigen Receptor (CAR) T Cell Therapies and Relative Risk: an EBMT-EHA-GoCART Coalition Statement

We need to bring your attention to the recent warning disseminated by the Food and Drug Administration (FDA) regarding T-cell lymphomas in patients undergoing Chimeric Antigen Receptor T-cell (CAR-T) therapy (1).

Read more

Multi-center acute myeloid leukemia study

An SWG Grant-supported project initiated by EHA's SWG on Acute Myeloid Leukemia.

Read more

Standards for functional precision medicine project

An SWG Grant-supported project initiated by EHA's SWG on Precision Hematology.

Read more

Long-lasting, late-onset, and chronic idiopathic neutropenia project

An SWG Grant-supported project initiated by EHA's SWG on Granulocytes and Constitutional Marrow Failure Disorders.

Read more

European registry on inherited platelet disorders project

An SWG Grant-supported project initiated by EHA's SWG on Thrombocytopenia and Platelet Function Disorders.

Read more

Register for EHA2025

Get ready to make new connections in Milan from June 12–15, 2025. Register now for EHA's reimagined Congress experience.

Read more

CAR NK-cells project

An SWG Grant-supported project initiated by EHA's SWG on Immune Therapies for Hematologic Disorders.

Read more

Belgium shares EU health priorities for Council Presidency

On December 8, Belgium held a conference to unveil its program for the upcoming Council of the EU Presidency (website), to start on January 1, 2024.

Read more

Guidelines endorsed by EHA

EHA will not accept endorsement requests until the end of 2025.

Read more

Participation grants & abstract awards

Participation grants
The call for participation grant applications has closed on March 1, 2021 (23:59 CET). Participation grant application has closed

Participation Grants (previously called Travel Grants) provide complimentary registration for the upcoming EHA Virtual Congress.

Read more